Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Одеський Національний Медичний УніверситетfiledCriticalОдеський Національний Медичний Університет
Priority to UAU201313837UpriorityCriticalpatent/UA89234U/en
Publication of UA89234UpublicationCriticalpatent/UA89234U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
A method for treating the vestibular dysfunctions in the chronic vertebrobasilar insufficiency provides for vitaminotherapy and antioxidant therapy. The vertical-mode vestibular adaptation therapy is used in the setting with exercises for gaze fixation at three targets at the eye level and the exercises for head rotation. Tanakan is used at a dose of 40 mg, 1 tablet or 1 mL of the oral solution; Vasobral is used at a dose of 1 tablet or 2 mL of the oral solution twice a day during the meals for one month; Diclofenac sodium is injected intramuscularly in a volume of 3 mL once a day for 5-6 days, later in tablets at a dose of 50 mg, 1 tablet twice a day for one week. Since the first day of the treatment, electrophoresis of 1.5 % solution of Neuromidin is applied onto the lateral projections of the cervical sympathetic trunk from the anode, 8-10 procedures, later Neuromidin is provided in tablets at a dose of 1 tablet (20 mg) twice a day for 12-14 days.
UAU201313837U2013-11-292013-11-29Method for treating vestibular dysfunctions in chronic vertebrobasilar insufficiency
UA89234U
(en)